185. HIV Co-Morbidities - Preventing and Managing End Organ Disease
Friday, October 28, 2016: 3:45 PM-5:45 PM
Room: Theater C

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss variables to monitor and treat renal disease in patients with HIV
  • describe variables to prevent and manage cardiac disease in patients with HIV
  • identify¬†advances in management of bone disease in patients with HIV
  • explain the potential effects of HIV infection on cognitive functioning¬†

Target Audience: Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Members-in-training, Public health practitioners

Tracks: HIV-STD-TB, Adult ID

Moderators:  Pablo Tebas, MD, FIDSA, University of Pennsylvania and Florence Momplaisir, MD MSHP, Drexel College of Medicine

3:45 PM
Kidney Disease
Christina Wyatt, MD

4:15 PM
Cardiovascular Disease
Michelle Floris-Moore, MD, MS
4:45 PM
Bone Disease
Ighovwerha Ofotokun, MD, MSc, FIDSA

CME Credits: Maximum of 2 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 2 knowledge-based contact hours .20 of pharmacy CE

ACPE Number: 0221-9999-16-272-L02-P


P. Tebas, Merck: Consultant , Consulting fee
Glaxo: Adjudication Committe member , Consulting fee

F. Momplaisir, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.